Aquaculture Vaccines Market To Reach $467.3 Million By 2033

Aquaculture Vaccines Market Growth & Trends

The global aquaculture vaccines market size is expected to reach USD 467.3 million by 2033, registering a CAGR of 9.41% from 2026 to 2033, according to a new report by Grand View Research, Inc. The advent of vaccines for fish has significantly reduced the dependency on antimicrobial agents. Vaccination programs help in protecting the animal health and livelihoods of those who work with livestock as well as aid in ensuring food security. The development of some aquaculture sectors, such as the salmon industry in Norway, wherein fish farmers in the country moved from using antibiotics to vaccines by 1994, demonstrates the potential of vaccines in reducing the dependence on veterinary medicines.

Similar to other markets, the market for aquaculture vaccines has also been significantly affected. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, low demand, growing awareness of animal to human disease transmission risks, and operational hurdles due to changing policies and restrictions.

The growing demand for aquatic animal-derived food products, such as oil, caviar, protein powders, and meat, is encouraging farmers to use vaccinations for aquaculture to gain higher profitability. Due to the rising urbanization, consumers are becoming more aware of the nutritious value of animal protein. The demand for healthy, sustainable, and high-quality meat products that have fewer or no drugs is also increasing rapidly. Thus, the need for healthy breeding of aquatic animals is increasing, which is expected to fuel the demand for aquaculture vaccines, thereby boosting the market growth.

The market for aquaculture vaccines is fairly competitive. The most notable participants in the market are Zoetis; Merck & Co., Inc.; and Elanco, along with other manufacturers of aquaculture vaccines. These players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in July 2020, Zoetis acquired Fish Vet Group from Benchmark Holdings, PLC. This added to the company’s Pharmaq business, which is involved in fish vaccines and services.

 Request a free sample copy or view report summary: Aquaculture Vaccines Market Report

Aquaculture Vaccines Market Report Highlights

• According to a study published in October 2025, in countries such as China, India, and Vietnam, disease outbreaks are responsible for over 30% of total aquaculture production losses. In addition, about 50% of global aquaculture losses are caused by disease, with a greater impact observed in developing nations.

• In addition, governments and regulatory authorities all around the globe are implementing policies promoting sustainable aquaculture and stricter biosecurity measures to curb antibiotic usage and disease outbreaks.

• Furthermore, innovations in biotechnology, such as recombinant DNA, yeast expression platforms, and multivalent vaccines, allow the production of highly effective, species-specific vaccines with minimal environmental impact.

• The aquaculture vaccine market is moderately concentrated, dominated by key global players such as Zoetis, Merck Animal Health, PHARMAQ (Zoetis), Virbac, and HIPRA. These companies leverage strong R&D capabilities, global distribution networks, and partnerships with aquaculture institutes, while regional players focus on autogenous and species-specific vaccines to meet local disease challenges..

• For instance, in February 2025, MSD Animal Health acquired Elanco’s aqua business, expanding its aquaculture portfolio with innovative vaccines, therapeutics, and facilities across Canada, Vietnam, and Chile to strengthen fish health, sustainability, and global reach

• On the basis of product, attenuated live vaccines segment held the largest revenue share of 49.99% in 2025, owing to their superior ability to induce long-lasting, robust immune responses in fish

• On the basis of route of administration, injected segment dominated with largest revenue share in 2025, due to its proven efficacy and ability to provide long-lasting, robust immunity in fish.

• On the basis of application, bacterial segment dominated the market with largest revenue share in 2025, owing to the high prevalence of bacterial infections in farmed fish, such as Aeromonas, Vibrio, and Edwardsiella species.

• On the basis of distribution channel, hospital/clinic pharmacy constituted the largest revenue segment in 2025. The market is expanding due its established distribution networks, direct access to veterinary professionals, and ability to provide timely and specialized vaccines

• North America dominated the market with largest revenue share of 38.03% in 2025. The market is driven by rising seafood consumption, increasing aquaculture production, and growing awareness of disease prevention to ensure fish health and yield.

Aquaculture Vaccines Market Segmentation

Grand View Research has segmented the global aquaculture vaccines market report based on product, application, route of administration, distribution channel, and region:

Aquaculture Vaccines Product Outlook (Revenue, USD Million, 2021 - 2033)

• Attenuated Live Vaccines

• Inactivated Vaccines

• Other Vaccines

Aquaculture Vaccines Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)

• Oral

• Injected

• Immersion & Spray

Aquaculture Vaccines Application Outlook (Revenue, USD Million, 2021 - 2033)

• Bacterial

• Viral

• Parasitic

Aquaculture Vaccines Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Retail

• E-Commerce

• Hospital/Clinic Pharmacy

Aquaculture Vaccines Region Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

  • Qatar

  • Oman

List of Key Players in Aquaculture Vaccines Market

• Zoetis

• Phibro Animal Health Corporation

• Elanco

• Merck & Co., Inc.

• KBNP

• CAVAC

• Kyoto Biken Laboratories, Inc.

• Nisseiken Co., Ltd.

• Vaxxinova International BV

• HIPRA